Christopher G. Smith
University of Cambridge(GB)Cancer Research UK(GB)NeoGenomics (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Melanoma and MAPK Pathways, Histone Deacetylase Inhibitors Research, Genetic factors in colorectal cancer, Renal cell carcinoma treatment
Most-Cited Works
- → Enhanced detection of circulating tumor DNA by fragment size analysis(2018)1,050 cited
- → Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial(2011)965 cited
- → Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33(2010)373 cited
- → Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer(2022)324 cited
- → Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk(2012)229 cited
- → Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients(2018)197 cited